FDA Blocks Drugs From Three Chinese API Makers After Record Refusals and Quality Failures Raise Risks for U.S. Patients
FDA Blocks Drugs From Three Chinese API Makers After Record Refusals and Quality Failures Raise Risks for U.S. Patients
Nov. 11, 2026, 10:36 p.m.